BOOTHBAY FUND MANAGEMENT, LLC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 51 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$26,000
-63.9%
45,108
-18.9%
0.00%
-50.0%
Q1 2022$72,000
+14.3%
55,5990.0%0.00%
+100.0%
Q4 2021$63,000
-25.9%
55,5990.0%0.00%
-50.0%
Q3 2021$85,000
-72.3%
55,599
-64.1%
0.00%
-80.0%
Q2 2021$307,000155,0690.01%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 306,338$564,0000.11%
PVG ASSET MANAGEMENT CORP 14,140$26,018,0000.08%
GSA CAPITAL PARTNERS LLP 160,775$296,0000.05%
Virtu Financial LLC 179,030$329,0000.02%
Allen Capital Group, LLC 23,685$44,0000.01%
McAdam, LLC 36,641$67,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 10,000$18,0000.01%
ZEKE CAPITAL ADVISORS, LLC 50,000$92,0000.01%
JGP Wealth Management, LLC 15,000$28,0000.01%
Onex Canada Asset Management Inc. 40,000$74,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders